ADNH(ADNH)
ADNH
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E |
|---|---|
| Revenue Avg | $395M |
| Low | $395M |
| High | $395M |
| EBITDA Avg | $-395M |
| Low | $-395M |
| High | $-395M |
| EBIT Avg | $-395M |
| Low | $-395M |
| High | $-395M |
| Net Income Avg | $103M |
| Low | $103M |
| High | $103M |
| EPS Avg | $39.39 |
| Low | $39.39 |
| High | $39.39 |
| Analysts (Rev / EPS) | 1 / 1 |
| Metric | Q3 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q1 2028 | Q2 2028 | Q3 2028 |
|---|---|---|---|---|---|---|---|
| Revenue Avg | $6M | $94,685 | $101,609 | $109,039 | $125,568 | $134,750 | $144,603 |
| Low | $6M | $94,685 | $101,609 | $109,039 | $125,568 | $134,750 | $144,603 |
| High | $6M | $94,685 | $101,609 | $109,039 | $125,568 | $134,750 | $144,603 |
| EBITDA Avg | $-6M | $-94,685 | $-101,609 | $-109,039 | $-125,568 | $-134,750 | $-144,603 |
| Low | $-6M | $-94,685 | $-101,609 | $-109,039 | $-125,568 | $-134,750 | $-144,603 |
| High | $-6M | $-94,685 | $-101,609 | $-109,039 | $-125,568 | $-134,750 | $-144,603 |
| EBIT Avg | $-6M | $-94,685 | $-101,609 | $-109,039 | $-125,568 | $-134,750 | $-144,603 |
| Low | $-6M | $-94,685 | $-101,609 | $-109,039 | $-125,568 | $-134,750 | $-144,603 |
| High | $-6M | $-94,685 | $-101,609 | $-109,039 | $-125,568 | $-134,750 | $-144,603 |
| Net Income Avg | $-11M | $-21M | $-18M | $-3M | $-15M | $-22M | $-18M |
| Low | $-11M | $-21M | $-18M | $-3M | $-15M | $-22M | $-18M |
| High | $-11M | $-21M | $-18M | $-3M | $-15M | $-22M | $-18M |
| EPS Avg | $-3.60 | $-7.20 | $-6.00 | $-0.90 | $-5.10 | $-7.50 | $-6.00 |
| Low | $-3.60 | $-7.20 | $-6.00 | $-0.90 | $-5.10 | $-7.50 | $-6.00 |
| High | $-3.60 | $-7.20 | $-6.00 | $-0.90 | $-5.10 | $-7.50 | $-6.00 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |